Quantinno Capital Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$690K Sell
63,851
-173,058
-73% -$1.55M ﹤0.01% 3008
2026
Q2
$2.23M Buy
236,909
+201,550
+570% +$1.81M ﹤0.01% 1888
2026
Q1
$288K Buy
35,359
+12,304
+53% +$112K ﹤0.01% 3053
2025
Q4
$155K Sell
23,055
-3,412
-13% -$25.7K ﹤0.01% 3089
2025
Q3
$229K Buy
26,467
+8,869
+50% +$69K ﹤0.01% 2666
2025
Q2
$111K Buy
+17,598
New +$117K ﹤0.01% 2494

Other funds holding NVAX

Quantinno Capital Management's NVAX Position: Q3 2026 in Review

Quantinno Capital Management reduced its Novavax (NVAX) stake by 73% in Q3 2026, selling an estimated $1.55M and leaving 63,851 shares worth $690K. The position accounts for ﹤0.01% of the portfolio, ranked #3008.

Quantinno Capital Management first reported a position in NVAX in Q2 2025 and has held it in 6 quarters since. The position peaked at $2.23M in Q2 2026. 259 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.

  • Quantinno Capital Management held 63,851 shares of Novavax worth $690K as of Q3 2026.
  • Quantinno Capital Management sold 173,058 Novavax shares in Q3 2026, an estimated $1.55M.
  • Novavax made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #3008 holding.
  • Quantinno Capital Management first reported a position in Novavax in Q2 2025 and has held it in 6 quarters since.
  • Quantinno Capital Management's Novavax position peaked at $2.23M in Q2 2026.
  • 259 funds tracked by Wall St. Rank held Novavax as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.